ERT Achieves Record Third Quarter Results & Recognizes 40% Growth

Share Article

Growth Driven by Consistent Cross-Product Line Sales and Rapid Adoption of Innovative Data Analytics / Workflow Solution

News Image
“Our Q3 results represent the value our new and returning customers see in ERT’s eClinical solutions,” said Jim Corrigan, President and CEO, ERT.

November 5, 2015 (PRWEB) November 05, 2015 -- ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions, today announced record bookings results throughout third quarter, 2015. Sales of its eClinical data collection and cloud-based data visualization/analytics solutions were up nearly 40% over the same time period in 2014 and resulted in the largest quarter in the company’s 40 year history.

ERT recognized consistent increased sales across its line of proven eClinical solutions, including electronic Clinical Outcome Assessments (eCOA), cardiac safety, respiratory services, and Insights Cloud™, its first-in-class integrated solution that harmonizes data from any eClinical system and leverages real-time data analytics to automate and optimize trial management workflows. This software as a service (SaaS) offering coalesces enterprise-wide data sources and applies configurable analytical algorithms to provide clinical trial sponsors and Clinical Research Organizations (CROs) with actionable insights, process optimization and relative performance trends.

By doing so, trial sponsors gain comprehensive insight into trial progress and risk indicators, which is critical for evaluating protocol compliance, site performance, and data quality issues.

“Our Q3 results represent the value our new and returning customers see in ERT’s eClinical solutions,” said Jim Corrigan, President and CEO, ERT. “We are extremely proud of the work we do every day to earn the trust of global pharmaceutical, biotech and CRO partners and find great satisfaction in delivering to them the highest quality data and insights they need in order to conduct effective and efficient clinical development programs.”

For more information on ERT’s eClinical solutions, visit http://www.ert.com.

About ERT
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions in centralized Cardiac Safety, Respiratory, Suicide Risk Assessment, electronic Clinical Outcome Assessments (eCOA) – which includes patient-, clinician-, observer- and performance-reported outcomes – and cloud-based analytics and performance metrics. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes and delivers safety and efficacy data critical to the approval, labeling and reimbursement of pharmaceutical products.

ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., and in Germany, Japan, Switzerland and the U.K.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Christine Tobin
ERT
+1 (412) 719-4568
Email >
Visit website